- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting GLS1 to cancer therapy through glutamine metabolism
Authors
Keywords
-
Journal
Clinical & Translational Oncology
Volume 23, Issue 11, Pages 2253-2268
Publisher
Springer Science and Business Media LLC
Online
2021-05-23
DOI
10.1007/s12094-021-02645-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
- (2020) Manabu Kodama et al. Nature Communications
- Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
- (2019) Lisha Xiang et al. Cell Death & Disease
- The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
- (2019) Xing Huang et al. Autophagy
- Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
- (2019) Nan Jin et al. Nature Communications
- GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway
- (2019) Jianbo Xi et al. EXPERIMENTAL CELL RESEARCH
- Recent Development of Small Molecule Glutaminase Inhibitors
- (2018) Minsoo Song et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism
- (2018) Qingqiu Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis
- (2018) Jiaqiu Li et al. MOLECULAR THERAPY
- Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma
- (2018) Meng Dong et al. OncoTargets and Therapy
- c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer
- (2018) Xuan Qu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
- (2018) Min Hu et al. GENE
- We're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of6-Diazo-5-oxo-L-norleucine
- (2018) Kathryn M. Lemberg et al. MOLECULAR CANCER THERAPEUTICS
- iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer
- (2018) Zhen Jiang et al. Proteomics Clinical Applications
- Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
- (2018) Binghua Li et al. EBioMedicine
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
- (2017) Arimichi Okazaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer
- (2017) Zhou Song et al. Oncology Letters
- Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
- (2017) Wei-Qun Lu et al. Oncotarget
- HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival
- (2016) Steve Stegen et al. Cell Metabolism
- Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
- (2016) Rana Rais et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
- (2016) Amira Elgogary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling
- (2016) Lili Guo et al. TUMOR BIOLOGY
- Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
- (2016) Jae-Seon Lee et al. Cell Death & Disease
- Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion
- (2016) Joon Hee Kang et al. Oncotarget
- Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells
- (2016) Junzhang Zhao et al. Oncotarget
- Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer
- (2015) Tiejun Pan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
- (2015) Lingqin Yuan et al. ENDOCRINE-RELATED CANCER
- Glutaminolysis and carcinogenesis of oral squamous cell carcinoma
- (2015) Marcel Cetindis et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol
- (2015) AIQIN FU et al. Molecular Medicine Reports
- MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
- (2015) Emelyn H. Shroff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
- (2015) et al. SCIENCE
- Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
- (2015) Xinyuan Xu et al. Oncotarget
- Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
- (2015) Decai Yu et al. Oncotarget
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
- (2015) Laura Brunelli et al. Oncotarget
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition
- (2014) Danielle B. Ulanet et al. PLoS One
- Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells
- (2014) Clint A. Stalnecker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells
- (2014) Jing Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA)
- (2014) K. Thangavelu et al. Scientific Reports
- Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors
- (2013) Ajit G. Thomas et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia
- (2013) L. Willems et al. BLOOD
- Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
- (2013) Amr Mohamed et al. Clinical Lung Cancer
- Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
- (2013) J.M. Mates et al. CURRENT MOLECULAR MEDICINE
- Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer
- (2013) Sewha Kim et al. ENDOCRINE-RELATED CANCER
- ErbB2 Activation Upregulates Glutaminase 1 Expression Which Promotes Breast Cancer Cell Proliferation
- (2013) Shuo Qie et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells
- (2013) Mercedes Martín-Rufián et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Control of glutamine metabolism by the tumor suppressor Rb
- (2013) M R Reynolds et al. ONCOGENE
- Analysis of glutamine dependency in non-small cell lung cancer
- (2012) A. Pieter J. van den Heuvel et al. CANCER BIOLOGY & THERAPY
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- (2012) Mariia O. Yuneva et al. Cell Metabolism
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors
- (2012) Krupa Shukla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism
- (2012) A. Cassago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
- (2012) Gregg L. Semenza TRENDS IN MOLECULAR MEDICINE
- Rho GTPases and their roles in cancer metabolism
- (2012) Kristin F. Wilson et al. TRENDS IN MOLECULAR MEDICINE
- An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression
- (2011) Natalie E. Simpson et al. BREAST CANCER RESEARCH AND TREATMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- Glutamine: pleiotropic roles in tumor growth and stress resistance
- (2011) Naval P. Shanware et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
- (2011) Hsiu-Ni Kung et al. PLoS Genetics
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Oxygen Sensors at the Crossroad of Metabolism
- (2009) Julián Aragonés et al. Cell Metabolism
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
- (2009) R J DeBerardinis et al. ONCOGENE
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Delta Protein Kinase C Interacts with the d Subunit of the F1F0ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester
- (2008) Tiffany Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search